Tag:
angioedema
Latest Headlines
Latest Headlines
UPDATED: Upstart Ra sheds stealth status, targets new drug class
Two years after Ra snagged an initial $10 million in venture cash, the company has hauled in a second tranche of $8.6 million and picked its disease target: hereditary angioedema, a rare and lethal immune system disorder.
ViroPharma, Halozyme tackle hereditary angioedema treatment
ViroPharma ( $VPHM ) and Halozyme ( $HALO ) said they have generated positive early data in a Phase II trial of a drug delivery platform used to treat hereditary angioedema, a life-threatening immune
